549 related articles for article (PubMed ID: 20664190)
1. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
[TBL] [Abstract][Full Text] [Related]
2. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.
Simsek E; Yesilyurt A; Pinarli F; Eyerci N; Ulus AT
Gene; 2014 Feb; 536(1):171-6. PubMed ID: 24334115
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
5. Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.
Charafeddine KM; Mahfouz RA; Ibrahim GY; Taher AT; Hoballah JJ; Taha AM
Clin Appl Thromb Hemost; 2010 Oct; 16(5):594-8. PubMed ID: 19520679
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
8. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
Glueck CJ; Wang P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
[TBL] [Abstract][Full Text] [Related]
9. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
[TBL] [Abstract][Full Text] [Related]
10. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
11. Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.
Kupeli E; Verdi H; Simsek A; Atac FB; Eyuboglu FO
Clin Appl Thromb Hemost; 2011; 17(6):E87-94. PubMed ID: 21078611
[TBL] [Abstract][Full Text] [Related]
12. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
Kabukcu S; Keskin N; Keskin A; Atalay E
Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
[TBL] [Abstract][Full Text] [Related]
13. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
14. [Genomic diagnosis of thrombophilia in women: clinical relevance].
Luxembourg B; Lindhoff-Last E
Hamostaseologie; 2007 Feb; 27(1):22-31. PubMed ID: 17279273
[TBL] [Abstract][Full Text] [Related]
15. Superficial venous thrombosis: prevalence of common genetic risk factors and their role on spreading to deep veins.
Milio G; Siragusa S; Minà C; Amato C; Corrado E; Grimaudo S; Novo S
Thromb Res; 2008; 123(2):194-9. PubMed ID: 18387654
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
17. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis.
Ozyurek E; Balta G; Degerliyurt A; Parlak H; Aysun S; Gürgey A
Clin Appl Thromb Hemost; 2007 Apr; 13(2):154-60. PubMed ID: 17456624
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
Eid SS; Rihani G
Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
[TBL] [Abstract][Full Text] [Related]
19. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
20. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]